Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review

Degenerative Neurological and Neuromuscular Disease
J I RojasE Cristiano

Abstract

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76 cases per 100,000 inhabitants per year. Considering the epidemiology of MS in Argentina, the total number of patients affected is estimated at 5,000-8,000 patients, with nearly 55%-65% of patients having a relapsing-remitting MS subtype of the disease. The aim of this review is to provide an overview of current and emerging treatments available in Argentina for patients with MS.

Software Mentioned

STRATIFY

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
J I RojasE Cristiano
Multiple Sclerosis and Related Disorders
S MellingerMarcos Burgos
Iranian Journal of Child Neurology
Soroor Inaloo, Saideh Haghbin
© 2021 Meta ULC. All rights reserved